Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:03:22.699Z.
Calculation as of: 2026-10-06T16:03:22.699Z.
Quote observation: 2026-10-06T15:55:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 87a3ef4e55b06d985fb23947e4d9ae6563d80488a3a61227015f8099389db825
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$670456.00
EV/EBIT Ratio
5.81x
TTM Avg
18.06x
3Y Avg
18.06x
5Y Avg
18.06x
Market Cap
$825495.00
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$885939.00
EV/EBIT Ratio
N/A
TTM Avg
1487.85x
3Y Avg
7742.21x
5Y Avg
7742.21x
Market Cap
$873327.00
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCW Biologics Inc. (HCWB) | $563178.00 | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $670456.00 | 5.81x | 18.06x | 18.06x | 18.06x |
| Niki BioSolutions, Inc. (NIKI)vs › | $388862.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $809925.00 | N/A | 6.10x | 6.10x | 6.10x |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $825495.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $848489.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | N/A | 1487.85x | 7742.21x | 7742.21x |
| Bone Biologics Corporation (BBLG)vs › | $873327.00 | N/A | N/A | N/A | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | N/A | N/A | N/A | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $94810.00 | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
